Annalisa Ruggeri, MD, PhD, obtained her medical degree from the University of Messina Medical School, Messina, Italy, in 2004. She completed her residency in hematology at the San Raffaele Vita-Salute University, Milan, Italy, in 2008, before completing her PhD in hematologic research at the University of Tor Vergata, Rome, Italy. Dr Ruggeri then completed training in clinical research statistics and methodology at the Pierre and Marie Curie University, Paris, France, and in clinical research project coordination at the Paris Diderot University, Paris, France.
Dr Ruggeri worked as a Junior Physician at the San Raffaele Hospital, Milan, Italy, between 2006 and 2007. In 2007, Dr Ruggeri was awarded with the EBMT-AMGEN fellowship which she undertook at the Hôpital Saint-Louis, Paris, France.
Since 2007, Dr Ruggeri has been working as a Research Physician at Eurocord where she coordinates research. Dr Ruggeri is also currently a Hematologist practising at IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, and undertakes research at the Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Speaking on acute leukemia and stem cell transplantation
Dr Ruggeri’s research interest lies in hematopoietic stem cell transplantation for acute leukemia, in particular acute myeloid leukemia (AML), with active involvement in studies looking into optimal transplant strategies. Dr Ruggeri is also a Principal Investigator for a Phase III trial (NCT02730299) investigating stem cell transplantation with omidubicel versus standard umbilical cord blood in patients with leukemia, lymphoma, and myelodysplastic syndrome (MDS).